Novartis To Buy Fenwick-Guided US Biotech Biz For $3.2B
Swiss pharmaceutical giant Novartis AG said on Monday that it has agreed to buy U.S. biotechnology firm Chinook Therapeutics for up to $3.5 billion, a move that will add two new drugs...To view the full article, register now.
Already a subscriber? Click here to view full article